Most Assets Die on Fit, Not on Data

Singapore, Sept. 2 -- "Almost every company preparing for a partnering conversation prepares for the wrong gate. The rejection usually happens earlier in the process than founders imagine, and for rea... Read More

Bridges Are Not Symmetrical: Reading the Asia Bio Cross-Border Keynote

Singapore, Sept. 2 -- Cross-border partnership is usually discussed as two parties meeting in the middle. The more accurate picture is a structure with one engineered end and one improvised end, and S... Read More

Ascletis doses first participant in global Phase III trial of oral GLP-1 candidate ASC30

Singapore, Sept. 2 -- Ascletis Pharma has dosed the first participant in its global Phase III clinical programme evaluating ASC30, an investigational once-daily oral small molecule GLP-1 receptor agon... Read More

Singapore becomes first ASEAN market to subsidise vutrisiran for transthyretin amyloidosis

Singapore, Sept. 2 -- Singapore has become the first ASEAN country to provide government subsidies for eligible patients receiving vutrisiran for transthyretin amyloidosis. From 1 September 2026, vut... Read More

Singapore expands subsidised access to Roche's Columvi for relapsed or refractory DLBCL

Singapore, Sept. 2 -- Singapore is expanding subsidised access to Roche's Columvi, or glofitamab, for eligible patients with relapsed or refractory diffuse large B-cell lymphoma. From 1 September 202... Read More

DIPG Alliance to raise S$5 M over five years to establish Singapore's first enduring paediatric brain tumour research fund

Singapore, Sept. 2 -- DIPG Alliance, Singapore's first charitable foundation dedicated to advancing research for Diffuse Intrinsic Pontine Glioma (DIPG) and other paediatric brain cancers, has been es... Read More

Two Days That Mapped the Next Phase of APAC Dealmaking

Singapore, Sept. 2 -- EVENT WRAP-UP | ASIA BIO PARTNERING FORUM 2026 A forum that met the moment Some conferences describe the industry. The better ones hold a mirror up to it at exactly the right t... Read More

China's Simcere Zaiming signs $1.5 B deal with Roche for SIM0660 global development

Singapore, Sept. 2 -- Simcere Zaiming, a subsidiary of China-based Simcere Pharmaceutical Group, has entered into an exclusive global licensing agreement with Roche for the development and commerciali... Read More

Korea's GC Biopharma collaborates with French firm Osivax to develop next-gen influenza vaccine

Singapore, Sept. 1 -- Osivax, a France based clinical-stage biopharmaceutical company developing differentiated influenza vaccines designed to generate broad-spectrum immune responses, and GC Biopharm... Read More

The New APAC Healthcare Equation: Innovation, Capital, AI and Global Scale

Singapore, Sept. 1 -- The most useful thing about an opening plenary is usually not what gets said. It is who the organisers decided to put on stage. The fourth edition of the Asia Bio Partnering For... Read More

• «
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• »
• »»